These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32753328)

  • 1. Torsades de Pointes in Coronavirus Disease 2019 Infection.
    Lalabekyan B; Kunst G; Skelton VA
    J Cardiothorac Vasc Anesth; 2021 Mar; 35(3):954-955. PubMed ID: 32753328
    [No Abstract]   [Full Text] [Related]  

  • 2. The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin.
    Chorin E; Dai M; Shulman E; Wadhwani L; Bar-Cohen R; Barbhaiya C; Aizer A; Holmes D; Bernstein S; Spinelli M; Park DS; Chinitz LA; Jankelson L
    Nat Med; 2020 Jun; 26(6):808-809. PubMed ID: 32488217
    [No Abstract]   [Full Text] [Related]  

  • 3. Safely Administering Potential QTc Prolonging Therapy Across a Large Health Care System in the COVID-19 Era.
    Saleh M; Gabriels J; Chang D; Fishbein J; Qiu M; Mountantonakis SE; Epstein LM;
    Circ Arrhythm Electrophysiol; 2020 Nov; 13(11):e008937. PubMed ID: 33003964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment.
    Roden DM; Harrington RA; Poppas A; Russo AM
    J Am Coll Cardiol; 2020 May; 75(20):2623-2624. PubMed ID: 32283123
    [No Abstract]   [Full Text] [Related]  

  • 5. Chloroquine-induced torsades de pointes in a patient with coronavirus disease 2019.
    Szekely Y; Lichter Y; Shrkihe BA; Bruck H; Oster HS; Viskin S
    Heart Rhythm; 2020 Sep; 17(9):1452-1455. PubMed ID: 32380291
    [No Abstract]   [Full Text] [Related]  

  • 6. QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.
    Wu TC; Sacilotto L; Darrieux FCDC; Pisani CF; Melo SL; Hachul DT; Scanavacca M
    Arq Bras Cardiol; 2020 Jun; 114(6):1061-1066. PubMed ID: 32638906
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiac arrhythmias in COVID-19 patients: A combination of viral comorbidities and pro-arrhythmic drug interactions.
    Ehrlich H; Elkbuli A
    Am J Emerg Med; 2021 Oct; 48():363-364. PubMed ID: 33551245
    [No Abstract]   [Full Text] [Related]  

  • 8. Torsades de pointes in SARS-CoV-2 (COVID-19) pneumonia: medicine reconciliation and careful monitoring of QTc interval may help prevent cardiac complications.
    Aslam W; Lamb CR; Ali N
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33762277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment.
    Roden DM; Harrington RA; Poppas A; Russo AM
    Heart Rhythm; 2020 Jul; 17(7):e231-e232. PubMed ID: 32302703
    [No Abstract]   [Full Text] [Related]  

  • 10. Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment.
    Roden DM; Harrington RA; Poppas A; Russo AM
    Circulation; 2020 Jun; 141(24):e906-e907. PubMed ID: 32267732
    [No Abstract]   [Full Text] [Related]  

  • 11. Torsades de pointes after adenosine administration.
    Teodorovich N; Margolin E; Kogan Y; Paz O; Swissa M
    J Electrocardiol; 2016; 49(2):171-3. PubMed ID: 26850499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole-associated QT interval prolongation and Torsades de Pointes in a paediatric patient.
    Ünal Yüksekgönül A; Ertuğrul İ; Karagöz T
    Cardiol Young; 2021 Dec; 31(12):2035-2037. PubMed ID: 34024302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review.
    Jankelson L; Karam G; Becker ML; Chinitz LA; Tsai MC
    Heart Rhythm; 2020 Sep; 17(9):1472-1479. PubMed ID: 32438018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and Cardiac Concerns for Psychiatric Patients.
    Alkasir A; Lippmann S
    Prim Care Companion CNS Disord; 2020 Dec; 22(6):. PubMed ID: 33271643
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine.
    Sarayani A; Cicali B; Henriksen CH; Brown JD
    Res Social Adm Pharm; 2021 Feb; 17(2):483-486. PubMed ID: 32327397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Torsades de pointes ventricular tachycardia associated with overdose of astemizole.
    Rao KA; Adlakha A; Verma-Ansil B; Meloy TD; Stanton MS
    Mayo Clin Proc; 1994 Jun; 69(6):589-93. PubMed ID: 8189766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Torsades de Pointes after Ondansetron Infusion in 2 Patients.
    Lee DY; Trinh T; Roy SK
    Tex Heart Inst J; 2017 Oct; 44(5):366-369. PubMed ID: 29259513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.
    Kühlkamp V; Mermi J; Mewis C; Seipel L
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):373-81. PubMed ID: 9125676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relations of QTc prolongation on the electrocardiogram to torsades de pointes: definitions and mechanisms.
    Morganroth J
    Am J Cardiol; 1993 Aug; 72(6):10B-13B. PubMed ID: 8256748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probable case of torsades de pointes induced by fluconazole.
    Khazan M; Mathis AS
    Pharmacotherapy; 2002 Dec; 22(12):1632-7. PubMed ID: 12495173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.